Broadfin Capital as of Sept. 30, 2015
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 84 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 24.4 | $437M | 4.0M | 109.20 | |
| Horizon Pharma | 7.9 | $142M | 7.2M | 19.82 | |
| Nevro (NVRO) | 4.7 | $84M | 1.8M | 46.39 | |
| Flamel Technologies | 4.0 | $72M | 4.4M | 16.31 | |
| Retrophin | 3.5 | $63M | 3.1M | 20.26 | |
| SPDR S&P Biotech (XBI) | 3.5 | $62M | 1.0M | 62.25 | |
| Heron Therapeutics (HRTX) | 3.2 | $58M | 2.4M | 24.40 | |
| Progenics Pharmaceuticals | 2.9 | $51M | 9.0M | 5.72 | |
| Emergent BioSolutions (EBS) | 2.6 | $46M | 1.6M | 28.49 | |
| AngioDynamics (ANGO) | 1.8 | $32M | 2.4M | 13.19 | |
| Aegerion Pharmaceuticals | 1.8 | $32M | 2.3M | 13.60 | |
| La Jolla Pharmaceuticl Com Par | 1.7 | $30M | 1.1M | 27.79 | |
| BioDelivery Sciences International | 1.6 | $28M | 5.0M | 5.56 | |
| Recro Pharma | 1.4 | $25M | 2.1M | 12.03 | |
| Novadaq Technologies | 1.1 | $20M | 1.9M | 10.43 | |
| Ignyta | 1.1 | $20M | 2.3M | 8.78 | |
| Dynavax Technologies (DVAX) | 1.1 | $19M | 790k | 24.54 | |
| Pernix Therapeutics Holdings | 1.1 | $19M | 6.1M | 3.16 | |
| Cardiovascular Systems | 1.1 | $19M | 1.2M | 15.84 | |
| Advaxis | 1.0 | $18M | 1.7M | 10.23 | |
| Idera Pharmaceuticals | 1.0 | $18M | 5.2M | 3.35 | |
| Corium Intl | 0.9 | $17M | 1.8M | 9.35 | |
| Masimo Corporation (MASI) | 0.9 | $16M | 422k | 38.56 | |
| Seaspine Holdings | 0.9 | $16M | 1.0M | 16.20 | |
| Kempharm | 0.9 | $16M | 800k | 19.38 | |
| Spectrum Pharmaceuticals | 0.8 | $15M | 2.5M | 5.98 | |
| IGI Laboratories | 0.8 | $15M | 2.3M | 6.54 | |
| Egalet | 0.8 | $15M | 1.1M | 13.18 | |
| Amphastar Pharmaceuticals (AMPH) | 0.8 | $15M | 1.3M | 11.69 | |
| Zogenix | 0.8 | $15M | 1.1M | 13.50 | |
| Antares Pharma | 0.8 | $14M | 8.5M | 1.70 | |
| Rigel Pharmaceuticals | 0.7 | $13M | 5.1M | 2.47 | |
| HeartWare International | 0.7 | $13M | 240k | 52.31 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.7 | $13M | 4.2M | 3.00 | |
| Lion Biotechnologies | 0.7 | $12M | 2.1M | 5.76 | |
| Medgenics | 0.7 | $12M | 1.5M | 7.82 | |
| Qlt | 0.7 | $12M | 4.4M | 2.66 | |
| Derma Sciences | 0.6 | $11M | 2.4M | 4.71 | |
| Aratana Therapeutics | 0.6 | $11M | 1.3M | 8.46 | |
| Trevena | 0.6 | $11M | 1.1M | 10.35 | |
| Pernix Therapeutics Hldgs In debt | 0.6 | $11M | 16M | 0.70 | |
| Redhill Biopharma Ltd cmn | 0.6 | $11M | 830k | 12.91 | |
| Spectranetics Corporation | 0.6 | $11M | 900k | 11.79 | |
| Mirati Therapeutics | 0.6 | $10M | 296k | 34.42 | |
| Paratek Pharmaceuticals | 0.6 | $10M | 530k | 19.00 | |
| Ardelyx (ARDX) | 0.5 | $9.5M | 549k | 17.28 | |
| Alcobra | 0.5 | $9.4M | 1.6M | 6.04 | |
| Cynapsus Therapeutics | 0.5 | $9.0M | 586k | 15.44 | |
| AtriCure (ATRC) | 0.5 | $8.8M | 404k | 21.91 | |
| Raptor Pharmaceutical | 0.5 | $8.5M | 1.4M | 6.05 | |
| Amarin Corporation (AMRN) | 0.5 | $8.1M | 4.2M | 1.93 | |
| Adma Biologics (ADMA) | 0.5 | $8.1M | 964k | 8.36 | |
| Syneron Medical Ltd ord | 0.4 | $7.5M | 1.1M | 7.15 | |
| Genocea Biosciences | 0.4 | $7.2M | 1.0M | 6.85 | |
| Biota Pharmaceuticals | 0.4 | $6.9M | 3.5M | 1.98 | |
| Anthera Pharmaceutcls | 0.4 | $7.0M | 1.2M | 6.09 | |
| Dipexium Pharmaceuticals | 0.4 | $6.5M | 466k | 14.00 | |
| Contrafect | 0.3 | $6.3M | 1.4M | 4.45 | |
| Fate Therapeutics (FATE) | 0.3 | $5.9M | 1.1M | 5.33 | |
| Tenax Therapeutics | 0.3 | $5.9M | 2.0M | 3.00 | |
| Scynexis | 0.3 | $5.6M | 775k | 7.28 | |
| Iradimed (IRMD) | 0.3 | $5.6M | 230k | 24.36 | |
| Flexion Therapeutics | 0.3 | $4.8M | 323k | 14.86 | |
| Tonix Pharmaceuticls | 0.3 | $4.7M | 891k | 5.29 | |
| Carbylan Therapeutics Inc Common Stock Usd 0.001 | 0.2 | $4.2M | 1.2M | 3.57 | |
| Mediwound Ltd cmn | 0.2 | $3.9M | 510k | 7.63 | |
| Accuray Incorporated (ARAY) | 0.2 | $3.7M | 750k | 4.99 | |
| Veracyte (VCYT) | 0.2 | $3.5M | 736k | 4.69 | |
| Epirus Biopharmaceuticals In | 0.2 | $3.4M | 775k | 4.42 | |
| CAS Medical Systems | 0.2 | $3.3M | 2.6M | 1.25 | |
| OraSure Technologies (OSUR) | 0.2 | $3.0M | 686k | 4.44 | |
| Discovery Laboratories | 0.2 | $2.8M | 9.5M | 0.30 | |
| Cardica | 0.1 | $2.4M | 8.9M | 0.27 | |
| Biodel | 0.1 | $2.3M | 5.2M | 0.44 | |
| Rxi Pharmaceuticals | 0.1 | $2.3M | 6.1M | 0.37 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $2.1M | 167k | 12.72 | |
| Ampliphi Biosciences | 0.1 | $2.2M | 552k | 3.95 | |
| Bovie Medical Corporation | 0.1 | $1.8M | 947k | 1.95 | |
| Oncothyreon | 0.1 | $1.6M | 592k | 2.74 | |
| Ritter Pharmaceuticals | 0.1 | $1.6M | 778k | 2.05 | |
| Mela Sciences | 0.1 | $1.5M | 1.3M | 1.14 | |
| Zosano Pharma | 0.1 | $1.5M | 372k | 3.96 | |
| Tetraphase Pharmaceuticals | 0.1 | $1.2M | 160k | 7.46 | |
| Palatin Technologies | 0.1 | $1.1M | 1.4M | 0.81 |
